Home Pharma Page 3

Pharma

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17, regardless of age and gender

Phase 3 trials: XARELTO vascular dose plus aspirin in treating...

Novartis demonstrates LDL-C reduction with inclisiran, an investigational siRNA cholesterol-lowering treatment

FDA Collaborates with AnaBios for Research on Human Primary Cardiomyocytes

Tenax Therapeutics Completes Enrollment in Phase 2 Pulmonary Hypertension Trial

FDA Approves New Indications for AltaThera’s Sotalol IV in AFib Patients

Positive Outcomes Using CytoSorb during Cardiac Surgery for Infective Endocarditits: Study

EC Approves Pfizer’s VYNDAQEL capsule for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Resverlogix Receives US FDA Breakthrough Therapy Designation for Apabetalone

AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV...

Inositec’s INS-3001 Significantly Reduces Cardiovascular Calcification in Proof-of-Concept Studies

1 234...9 Page 3 of 9

MOST POPULAR

Penumbra Announces FDA Clearance of RED 62 Perfusion Catheter

Miami Cardiac & Vascular Institute Receives Certification of Excellence in Transcatheter...

CentraCare First in World to Use 4D Hologram Technology to Successfully...

Robocath and Rennes University Hospital launch co-development research program into treatment...

Load more

HOT NEWS